Coenzyme Q10 (CoQ10) plays a critical role in mitochondrial oxidative phosphorylation by 31 serving as an electron carrier in the respiratory electron transport chain. CoQ10 also functions 32 as a lipid-soluble antioxidant by protecting lipids, proteins and DNA damaged by oxidative 33 stress. CoQ10 deficiency has been associated with a number of human diseases including 34 mitochondrial diseases, neurodegenerative disorders, cardiovascular diseases, diabetes, 35 cancer, and with the ageing process. In many of these conditions CoQ10 supplementation 36 therapy has been effective in slowing or reversing pathological changes. Oxidative stress is a 37 major contributory factor in the process of retinal degeneration. In this brief review, we 38 summarize the functions of CoQ10 and highlight its use in the treatment of age-related 39 macular degeneration and glaucoma. In light of these data we propose that CoQ10 could have 40 therapeutic potential for other retinal diseases. 41 42
As oxidative stress also plays a critical role in the pathogenesis of retinitis pigmentosa and 265 diabetic retinopathy, so CoQ10 has potential for the treatment of both diseases. Figure 4F ), is considered to be a severe phase and is defined by retinal ischemia and 312 increased rate of abnormal neovascularization in the retina, optic disc and iris with vitreous or 313 pre-retinal haemorrhage. The fifth stage, diabetic macular edema (DME, Figure 4G high glucose treated cells has revealed that these anti-oxidants may exhibit different gene 331 expression patterns and activity; the activity of catalase, SODs and GPXs were reported to be 332 low in diabetic patients, animal models and high glucose treated cells compared to normal 333 control (78-81). Thus, a therapeutic strategy to directly decrease ROS production and 334 enhance expression of these anti-oxidants will protect the retina from oxidative stress damage 335 during DR. 
